Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Nicolaus, Kroeger"'
This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying b
Autor:
Alois Gratwohl, Rafael Duarte, John A. Snowden, Anja van Biezen, Helen Baldomero, Jane Apperley, Jan Cornelissen, Hildegard T. Greinix, Eoin Mc Grath, Mohamad Mohty, Nicolaus Kroeger, Arnon Nagler, Dietger Niederwieser, Hein Putter, Ronald Brand
Publikováno v:
EClinicalMedicine, Vol 15, Iss , Pp 33-41 (2019)
Background: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. Methods: This Retros
Externí odkaz:
https://doaj.org/article/4b3ac3890f7f46f5a47f20c03e58cd04
Autor:
Dina Averbuch, Rafael de la Camara, Gloria Tridello, Nina Simone Knelange, Tatiana A. Bykova, Marianne Ifversen, Veronika Dobsinska, Mouhab Ayas, Amir Ali Hamidieh, Herbert Pichler, Antonio Perez-Martinez, Simone Cesaro, Mikael Sundin, Isabel Badell, Peter Bader, Jan-Erik Johansson, Oana Mirci-Danicar, Petr Sedlacek, Catherine Paillard, Brenda Gibson, Sarah Lawson, Nicolaus Kroeger, Selim Corbacioglu, Malgorzata Mikulska, Jose Luis Piñana, Jan Styczynski, Per Ljungman
Publikováno v:
Bone Marrow Transplantation. 58:558-566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0409c21c94dc4a71656be8f424209a9b
https://doi.org/10.1038/s41409-023-01941-5
https://doi.org/10.1038/s41409-023-01941-5
Autor:
Annalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, Boris Afanasyev, Jan J. Cornelissen, Ahmet Elmaagacli, Maija Itälä-Remes, Didier Blaise, Ellen Meijer, Yener Koc, Noel Milpied, Harry C. Schouten, Nicolaus Kroeger, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Background Experience using post-transplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation (HSCT) from matched sibling donors (MSD) or unrelated donors (UD) is limited and wit
Externí odkaz:
https://doaj.org/article/2d1c8d7b81804ce4b88caa3dea2f1dc3
Autor:
Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, Nicolaus Kroeger, Mutlu Arat, Keith M. O. Wilson, Jacques-Olivier Bay, Arnold Ganser, Hans Martin, Jakob Passweg, Panagiotis D. Kottaridis, Ibrahim Yakoub-Agha, Rocio Parody Porras, Eva Maria Wagner, Jordi Esteve, Francesco Lanza, Arnon Nagler, Mohamad Mohty
Publikováno v:
Bone Marrow Transplantation. 57:1556-1563
Measurable residual disease (MRD) assessment before allogeneic hematopoietic cell transplantation (HCT) may help physicians to identify a subgroup of patients at high risk of relapse for de novo acute myeloid leukemia (AML) but its relevance among pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7587185aa8fee40f781de8f97fc7335b
https://doi.org/10.1038/s41409-022-01748-w
https://doi.org/10.1038/s41409-022-01748-w
Autor:
Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles Craddock, Eva Wagner-Drouet, Jurjen Versluis, thomas schroeder, Igor-Wolfgang Blau, Gerald Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus Kroeger, Victoria Potter, Edouard Forcade, Jakob Passweg, Regis Peffault de Latour, Johan Maertens, Keith Wilson, Jean Henri Bourhis, Jürgen Finke, Eolia Brissot, Ali Bazarbachi, Sebastian Giebel, Bipin N. Savani, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
The intensity of the conditioning regimen given before allogeneic hematopoietic cell transplantation (allo-HCT) can vary substantially. To confirm the ability of the recently developed transplant conditioning intensity (TCI) score to stratify the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99edebf89481944a55d0c2c0b6139667
https://doi.org/10.21203/rs.3.rs-2658231/v1
https://doi.org/10.21203/rs.3.rs-2658231/v1
Autor:
Victoria Potter, Luuk Gras, Anja van Biezen, Nicolaus Kroeger, Katja Sockel, Arnold Ganser, Jürgen Finke, helene labussiere, Regis Peffault de Latour, Yener Koc, Lone Friis, Urpu Salmenniemi, Pavel Jindra, Thomas Schroeder, Johanna Tischer, Mutlu Arat, María Pascual, Liesbeth de Wreede, Patrick Hayden, Kavita Raj, Joanna Drozd-solowska, Christof Scheid, Donal McLornan, Marie Robin, Ibrahim Yakoub-Agha
The optimal conditioning for patients with higher risk MDS receiving potentially curative allogeneic haematopoietic stem cell transplant(allo-HCT) remains to be defined. This is particularly the case for patients with excess of blasts at time of allo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e410304f47490b571d326c77530e8d
https://doi.org/10.21203/rs.3.rs-2604480/v1
https://doi.org/10.21203/rs.3.rs-2604480/v1
Autor:
Bertram Glass, Anna Sureda, Ariane Boumendil, Peter Dreger, Paolo Corradini, Ron Ram, Nicolaus Kroeger, Luca Castagna, Thomas Pabst, Mi Kwon, Gerald Wulf, Alejandro Martín García-Sancho, Carlos Solano, Matthias Stelljes, Hans Christian Reinhardt, Marie Thérèse Rubio, Ram Malladi, Didier Blaise, Caroline Besley, Edouard Forcade, Malte von Bonin, Jürgen Finke, Inken Hilgendorf, Joaquín Martínez-López, Jose A. Perez-Simon, Wolfgang Bethge, Norbert Schmitz
Publikováno v:
Blood. 140:7509-7511
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac3b9ac008ee916fe0d1d5aad34ba4ce
https://doi.org/10.1182/blood-2022-169459
https://doi.org/10.1182/blood-2022-169459
Autor:
Ali Bazarbachi, iman abou dalle, Myriam Labopin, thomas schroeder, Jürgen Finke, Matthias Stelljes, Andreas neubauer, Didier Blaise, Ibrahim Yakoub Agha, Urpu Salmenniemi, Edouard Forcade, Maija Itälä-Remes, Peter Dreger, Gesine Bug, Michael Heuser, Goda Choi, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Mohamad Mohty, Nicolaus Kroeger, Jakob Passweg
in press Pre-transplant detectable measurable residual disease (MRD) is still associated with high risk of relapse and poor outcomes in acute myeloid leukemia (AML). We aimed at evaluating the impact of disease burden on prediction of relapse and sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c533fdef3f376612632f9951e12a351
https://www.ncbi.nlm.nih.gov/pubmed/37041215
https://www.ncbi.nlm.nih.gov/pubmed/37041215
Autor:
Ameya Shrinivas Kunte, Nico Gagelmann, Anita Badbaran, Carolina Berger, Radwan Massoud, Evgeny Klyuchnikov, Christine Wolschke, Dietlinde Janson, Ulrike Fritsche-Friedland, Boris Fehse, Nicolaus Kroeger, Francis A. Ayuk
Publikováno v:
Blood. 140:7531-7532
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7306d61f6dc026cfc63d869d5cd68a82
https://doi.org/10.1182/blood-2022-168667
https://doi.org/10.1182/blood-2022-168667